Quest Diagnostics Inc (DGX) Operating Margin
- Operating margin · 12 months: Value 14.10%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 14.10% | Operating income / revenue. Period ending 2026-06-30. $1.63B ÷ $11.56B × 100 ≈ 14.10% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.63B USD | Operating Income (Loss) |
| Revenue | 11.56B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | 2.04B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.63B | $11.56B | (m) | (m) | $2.04B | 14.10% |
| 2026-03-31 | $1.61B | $11.28B | (m) | (m) | $2.00B | 14.27% |
| 2025-12-31 | $1.56B | $11.04B | (m) | (m) | $1.97B | 14.10% |
| 2025-09-30 | $1.53B | $10.85B | (m) | (m) | $1.93B | 14.11% |
| 2025-06-30 | $1.48B | $10.52B | (m) | (m) | $1.88B | 14.02% |
| 2025-03-31 | $1.39B | $10.16B | (m) | (m) | $1.81B | 13.70% |
| 2024-12-31 | $1.35B | $9.87B | (m) | (m) | $1.77B | 13.63% |
| 2024-09-30 | $1.25B | $9.54B | (m) | (m) | $1.71B | 13.13% |
| 2024-06-30 | $1.26B | $9.35B | (m) | (m) | $1.64B | 13.52% |
| 2024-03-31 | $1.26B | $9.29B | (m) | (m) | $1.64B | 13.54% |
| 2023-12-31 | $1.26B | $9.25B | (m) | (m) | $1.64B | 13.64% |
| 2023-09-30 | $1.13B | $9.30B | (m) | (m) | $1.80B | 12.15% |
| 2023-06-30 | $1.18B | $9.49B | (m) | (m) | $1.88B | 12.44% |
| 2023-03-31 | $1.22B | $9.60B | (m) | (m) | $1.89B | 12.70% |
| 2022-12-31 | $1.43B | $9.88B | (m) | (m) | $1.87B | 14.45% |
| 2022-09-30 | $1.83B | $10.29B | (m) | (m) | $1.77B | 17.77% |
| 2022-06-30 | $2.09B | $10.58B | (m) | (m) | $1.74B | 19.74% |
| 2022-03-31 | $2.23B | $10.68B | (m) | (m) | $1.75B | 20.92% |
| 2021-12-31 | $2.38B | $10.79B | (m) | (m) | $1.73B | 22.07% |
| 2021-09-30 | $2.64B | $11.05B | (m) | (m) | $1.71B | 23.90% |
| 2021-06-30 | $2.71B | $11.06B | (m) | (m) | $1.68B | 24.47% |
| 2021-03-31 | $2.46B | $10.34B | (m) | (m) | $1.61B | 23.76% |
| 2020-12-31 | $1.97B | $9.44B | (m) | (m) | $1.55B | 20.89% |
| 2020-09-30 | $1.54B | $8.36B | (m) | (m) | $1.45B | 18.41% |
| 2020-06-30 | $1.13B | $7.53B | (m) | (m) | $1.42B | 15.06% |
| 2020-03-31 | $1.16B | $7.66B | (m) | (m) | $1.42B | 15.12% |
| 2019-12-31 | $1.23B | $7.73B | (m) | (m) | $1.46B | 15.93% |
| 2019-09-30 | $1.09B | $7.64B | (m) | (m) | $1.46B | 14.24% |
| 2019-06-30 | $1.08B | $7.57B | (m) | (m) | $1.46B | 14.25% |
| 2019-03-31 | $1.08B | $7.54B | (m) | (m) | $1.45B | 14.29% |
| 2018-12-31 | $1.10B | $7.53B | (m) | (m) | $1.42B | 14.62% |
| 2018-09-30 | $1.15B | $7.86B | (m) | (m) | $1.76B | 14.62% |
| 2018-06-30 | $1.14B | $7.83B | (m) | (m) | $1.75B | 14.61% |
| 2018-03-31 | $1.16B | $7.78B | (m) | (m) | $1.76B | 14.89% |
| 2017-12-31 | $1.17B | $7.71B | (m) | (m) | $1.75B | 15.11% |
| 2017-09-30 | $1.17B | $7.63B | (m) | (m) | $1.70B | 15.35% |
| 2017-06-30 | $1.20B | $7.59B | (m) | (m) | $1.68B | 15.76% |
| 2017-03-31 | $1.30B | $7.55B | (m) | (m) | $1.68B | 17.20% |
| 2016-12-31 | $1.28B | $7.51B | (m) | (m) | $1.68B | 16.99% |
| 2016-09-30 | $1.24B | $7.50B | (m) | (m) | $1.71B | 16.53% |
| 2016-06-30 | $1.55B | $7.50B | (m) | (m) | $1.70B | 20.66% |
| 2016-03-31 | $1.43B | $7.52B | (m) | (m) | $1.70B | 19.00% |
| 2015-12-31 | $1.40B | $7.49B | (m) | (m) | $1.68B | 18.67% |
| 2015-09-30 | $1.42B | $7.53B | (m) | (m) | $1.68B | 18.83% |
| 2015-06-30 | $1.04B | $7.55B | (m) | (m) | $1.72B | 13.80% |
| 2015-03-31 | $1.00B | $7.53B | (m) | (m) | $1.73B | 13.32% |
| 2014-12-31 | $983.00M | $7.43B | (m) | (m) | $1.73B | 13.22% |
| 2014-09-30 | $996.00M | $7.31B | (m) | (m) | $1.72B | 13.63% |
| 2014-06-30 | $1.43B | $7.19B | (m) | (m) | $1.69B | 19.87% |
| 2014-03-31 | $1.46B | $7.11B | (m) | (m) | $1.67B | 20.49% |
| 2013-12-31 | $1.48B | $7.15B | (m) | (m) | $1.70B | 20.64% |
| 2013-09-30 | $1.47B | $7.16B | (m) | (m) | $1.71B | 20.52% |
| 2013-06-30 | $1.09B | $7.20B | (m) | (m) | $1.70B | 15.08% |
| 2013-03-31 | $1.13B | $7.26B | (m) | (m) | $1.71B | 15.56% |
| 2012-12-31 | $1.20B | $7.38B | (m) | (m) | $1.75B | 16.27% |
| 2012-09-30 | $1.27B | $7.57B | (m) | (m) | $1.83B | 16.74% |
| 2012-06-30 | $1.28B | $7.63B | (m) | (m) | $1.85B | 16.80% |
| 2012-03-31 | $1.26B | $7.63B | (m) | (m) | $1.87B | 16.57% |
| 2011-12-31 | $995.05M | $7.51B | (m) | (m) | $1.81B | 13.25% |
| 2011-09-30 | $964.08M | $7.46B | (m) | (m) | $1.79B | 12.93% |
| 2011-06-30 | $978.89M | $7.41B | (m) | (m) | $1.77B | 13.20% |
| 2011-03-31 | $1.03B | $7.38B | (m) | (m) | $1.72B | 13.92% |
| 2010-12-31 | $1.30B | $7.37B | (m) | (m) | $1.71B | 17.58% |
| 2010-09-30 | $1.33B | $7.39B | (m) | (m) | $1.71B | 18.01% |
| 2010-06-30 | $1.34B | $7.43B | (m) | (m) | $1.72B | 18.09% |
| 2010-03-31 | $1.34B | $7.45B | (m) | (m) | $1.75B | 17.93% |
| 2009-12-31 | $1.36B | $7.46B | (m) | (m) | $1.75B | 18.23% |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $1.22B | $7.25B | (m) | (m) | $1.74B | 16.86% |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $1.09B | $6.70B | (m) | (m) | $1.61B | 16.28% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |